140 related articles for article (PubMed ID: 29144162)
1. Association Between Metformin Adherence and All-Cause Mortality Among New Users of Metformin: A Nested Case-Control Study.
Simard P; Presse N; Roy L; Dorais M; White-Guay B; Räkel A; Perreault S
Ann Pharmacother; 2018 Apr; 52(4):305-313. PubMed ID: 29144162
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.
Azoulay L; Schneider-Lindner V; Dell'aniello S; Schiffrin A; Suissa S
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):335-42. PubMed ID: 20052677
[TBL] [Abstract][Full Text] [Related]
3. Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.
Johnson JA; Majumdar SR; Simpson SH; Toth EL
Diabetes Care; 2002 Dec; 25(12):2244-8. PubMed ID: 12453968
[TBL] [Abstract][Full Text] [Related]
4. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis.
Vanderpoel DR; Hussein MA; Watson-Heidari T; Perry A
Clin Ther; 2004 Dec; 26(12):2066-75. PubMed ID: 15823770
[TBL] [Abstract][Full Text] [Related]
5. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
[TBL] [Abstract][Full Text] [Related]
6. Adherence to oral antidiabetic agents with pioglitazone and metformin: comparison of fixed-dose combination therapy with monotherapy and loose-dose combination therapy.
Barner JC
Clin Ther; 2011 Sep; 33(9):1281-8. PubMed ID: 21840054
[TBL] [Abstract][Full Text] [Related]
7. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U
Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546
[TBL] [Abstract][Full Text] [Related]
8. Risk of Cause-Specific Death in Individuals with Cancer-Modifying Role Diabetes, Statins and Metformin.
Haukka J; Niskanen L; Auvinen A
Int J Cancer; 2017 Dec; 141(12):2437-2449. PubMed ID: 28840596
[TBL] [Abstract][Full Text] [Related]
9. Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care.
Hippisley-Cox J; Coupland C
BMJ; 2016 Jul; 354():i3477. PubMed ID: 27413012
[TBL] [Abstract][Full Text] [Related]
10. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
Adeyemi AO; Rascati KL; Lawson KA; Strassels SA
Clin Ther; 2012 Mar; 34(3):712-9. PubMed ID: 22381712
[TBL] [Abstract][Full Text] [Related]
11. Persistence and adherence to oral antidiabetics: a population-based cohort study.
Simard P; Presse N; Roy L; Dorais M; White-Guay B; Räkel A; Perreault S
Acta Diabetol; 2015 Jun; 52(3):547-56. PubMed ID: 25524433
[TBL] [Abstract][Full Text] [Related]
12. Adherence to metformin and the onset of rheumatoid arthritis: a population-based cohort study.
Naffaa ME; Rosenberg V; Watad A; Tiosano S; Yavne Y; Chodick G; Amital H; Shalev V
Scand J Rheumatol; 2020 May; 49(3):173-180. PubMed ID: 32208872
[No Abstract] [Full Text] [Related]
13. Metformin adherence in patients with type 2 diabetes and its association with glycated haemoglobin levels.
Chepulis L; Mayo C; Morison B; Keenan R; Lao C; Paul R; Lawrenson R
J Prim Health Care; 2020 Dec; 12(4):318-326. PubMed ID: 33349319
[TBL] [Abstract][Full Text] [Related]
14. Depression and antecedent medication adherence in a cohort of new metformin users.
Niaz D; Necyk C; Simpson SH
Diabet Med; 2021 Feb; 38(2):e14426. PubMed ID: 33064895
[TBL] [Abstract][Full Text] [Related]
15. Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes.
Florez H; Luo J; Castillo-Florez S; Mitsi G; Hanna J; Tamariz L; Palacio A; Nagendran S; Hagan M
Postgrad Med; 2010 Mar; 122(2):112-20. PubMed ID: 20203462
[TBL] [Abstract][Full Text] [Related]
16. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients.
Cheong C; Barner JC; Lawson KA; Johnsrud MT
Clin Ther; 2008 Oct; 30(10):1893-907. PubMed ID: 19014846
[TBL] [Abstract][Full Text] [Related]
17. Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study.
Hung SC; Chang YK; Liu JS; Kuo KL; Chen YH; Hsu CC; Tarng DC
Lancet Diabetes Endocrinol; 2015 Aug; 3(8):605-14. PubMed ID: 26094107
[TBL] [Abstract][Full Text] [Related]
18. Regional variation in medication-taking behaviour of new users of oral anti-hyperglycaemic therapy in Ireland.
O'Shea MP; Teeling M; Bennett K
Ir J Med Sci; 2015 Jun; 184(2):403-10. PubMed ID: 24859371
[TBL] [Abstract][Full Text] [Related]
19. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
[TBL] [Abstract][Full Text] [Related]
20. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
Oladapo AO; Barner JC; Rascati KL; Strassels SA
Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
